Publisher
Springer International Publishing
Reference75 articles.
1. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139
2. Ahmad A, Sarkar FH (2012) Current understanding of drug resistance mechanisms and therapeutic targets in HER2 overexpressing breast cancers. In: Ahmad A (ed) Breast cancer metastasis and drug resistance. Springer, Place Published, New York, pp 261–274
3. Stern DF, Heffernan PA, Weinberg RA (1986) p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol 6:1729–1740
4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182
5. Browne BC, O’Brien N, Duffy MJ, Crown J, O’Donovan N (2009) HER-2 signaling and inhibition in breast cancer. Curr Cancer Drug Targets 9:419–438
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献